Advertisement
Advertise with us
sidenav

CTP Science Office Once Expected to Grant E-Liquid Authorizations

Advertisement
Advertise with us

The FDA Center for Tobacco Products (CTP) at one point expected to authorize bottled e-liquids from manufacturers that submitted premarket tobacco applications (PMTAs). The FDA tobacco center’s Office of Science submitted a memo outlining a plan to speed up review of e-liquids, according to an exclusive story by Alex Norcia in Filter.

The memo, titled “Bundling and Bracketing Approach for Review of ENDS Open E-liquid PMTAs,” described a process to expedite scientific review of PMTAs for e-liquids by grouping products based on characterizing flavors, using a “flavor wheel” first published in a 2019 paper by a group of Dutch scientists. FDA scientific reviewers could have reviewed multiple products by a single manufacturer, and then bridged their conclusions to additional products included in that company’s PMTA.

The plan was intended as a time-saver for FDA scientific reviewers, but it also acknowledged the agency’s belief at the time that some bottled e-liquids would be authorized.

The memo was signed by then-Office of Science Director Matthew Holman, who recently left the FDA to work for tobacco company Philip Morris International. Filter obtained the memo from the FDA through a Freedom of Information Act (FOIA) request. (The full memo can be read in the Filter article.)

🔎👀🔍 pic.twitter.com/qikDF0n6dS

— American Vapor Manufacturers (@VaporAmerican) August 10, 2022

The planned “bundling and bracketing” system for PMTA reviews was intended to make the CTP’s job easier, but its author also said it would “increase the likelihood that more tobacco products will be reviewed and receive marketing orders before the end of the compliance period.” ("Compliance period” referred to the one-year period following the Sept. 9, 2020 PMTA submission deadline during which submitted products could be sold without the threat of FDA enforcement.)

“Essentially,” writes Norcia, “CTP seems to have imagined a couple of years ago that an expedited process would efficiently produce large numbers of marketing denials and authorizations for open-system vapes and e-liquids.” Open-system vapes are devices that can be refilled with bottled e-liquid, and the bottled e-liquid itself.

As it turns out, the FDA still hasn’t authorized a single open-system product, not even tobacco-flavored or unflavored products. Instead the agency chose to implement a review system designed to reject PMTAs for all flavored products without any review—unless manufacturers submitted expensive and time-consuming studies to prove their products provided “enough of a benefit to adult smokers that would overcome the risk posed to youth.”

Without randomized controlled trials or longitudinal cohort studies, the agency assumed (based on scant evidence) that non-tobacco flavored products were not “appropriate for the protection of public health” and issued marketing denial orders (MDOs). The FDA denied applications for millions of products submitted by hundreds of manufacturers, and was taken to court by dozens of small companies.

Yet again, internal FDA memo surfaces outlining their shadowy process for review. Conveniently, this document appears after the appeals have been litigated. Clearly the process was rigged against small business from the beginning. What other shady secrets will be discovered? https://t.co/KoMq9fO1DM

— Amanda Wheeler (@amandawheeler32) August 10, 2022

The companies challenging the FDA in federal courts might have made good use of the “bundling and bracketing” memo—if they had seen it before their cases were decided. At the very least, it shows the CTP had envisioned authorizing some open-system products (although not necessarily flavored products), but instead someone at the FDA nixed the idea in favor of the boilerplate denial system the agency settled on.

The memo laid out a plan for CTP scientific reviewers from the Division of Product Science and Division of Nonclinical Science to randomly choose products with up to 24 characterizing flavors from a single company’s PMTA, and then to bridge the reviewers’ conclusions to other products included in the same application. The memo writer said there would be “no limit to the maximum number of tobacco products per PMTA for which the conclusions can be bridged.”

Manufacturers, of course, weren’t allowed to make assumptions about any of their own products based on information about other similar submitted products. That would have been a time- and effort-saving shortcut only granted to hard-working CTP reviewers. But the very existence of the “bundling and bracketing” memo shows the FDA recognized the foolishness of its demand that each (very similar) product be subjected to identical tests that would in all likelihood show the exact same results across a given company's product line.

Advertisement
Advertise with us
Latest Reviews
Article preview image
Freemax REXA PRO & REXA SMART Review: Too Smart?

The Freemax REXA PRO and REXA SMART are highly advanced pod vapes, offering seemingly endless features, beautiful touchscreens, and new DUOMAX pods.

Wed Jul 30 2025
Article preview image
OXVA XLIM Pro 2 DNA Review: A Match Made in Heaven!

The OXVA XLIM Pro 2 DNA is powered by a custom-made Evolv DNA chipset, offering a Replay function and dry hit protection. Read our review to find out more.

Fri Jul 18 2025
Article preview image
SKE Bar Review: A Reusable Crystal Bar!

The SKE Bar is a 2 mL replaceable pod vape with a 500 mAh battery, a 1.2-ohm mesh coil, and 35 flavors to choose from in 2% nicotine.

Mon Jul 7 2025
Advertisement
Advertise with us
Latest Learn
vaping taxes
Vaping Taxes in the United States and Around the World

Because of declining cigarette sales, state governments in the U.S. and countries around the world are looking to vapor products as a new source of tax revenue.

Thu Jul 31 2025
How Old Do You Have to Be to Vape?
How Old Do You Have to Be to Vape?

The legal age to buy e-cigarettes and other vaping products varies around the world. The United States recently changed the legal minimum sales age to 21.

Tue Jul 1 2025
Where vaping is banned or restricted
Vape Bans: E-Cigarette Restrictions in the U.S. and Worldwide

A list of vaping product flavor bans and online sales bans in the United States, and sales and possession bans in other countries.

Fri Jul 4 2025
About Authors
Jim McDonald
844 posts

Smokers created vaping for themselves without help from the tobacco industry or anti-tobacco crusaders, and I believe vapers and the vaping industry have the right to continue innovating to give everyone who wants to use nicotine access to safe and attractive non-combustible options. My goal is to provide clear, honest information about vaping and the challenges nicotine consumers face from lawmakers, regulators, and brokers of disinformation. You can find me on Twitter @whycherrywhy

See author’s profile
Vaping360.com strives to be the world's most trusted resource for vapers and smokers. We take pride in our editorial integrity, accuracy, and the honesty of our writers.
Read more about us

Rely on Our Expertise

At Vaping360, we take pride in our deep expertise and years of experience in the vaping industry. Our dedicated team of professionals is committed to leveraging their extensive knowledge to meet your needs and exceed your expectations.

Authenticity

Genuine insights backed by thorough and exhaustive research and testing.

Reliability

Consistent, accurate information from the vaping industry experts.

Empowerment

Transparent and reliable content for confident and informed decision-making.

About us

Our mission is clear: to help people who smoke transition to low-risk alternatives and contribute to a smoke-free world. With each article we publish and each review we conduct, we're working towards this goal.

about-us-banner
product preview